Osteoarthritis Study published on EuroPharma’s BCM-95 Curcumin and Bos-Pur Boswellia

In late 2011, a study was presented to the Osteoarthritis Research Symposium Internationale (OARSI), comparing BCM-95 and Bos-Pur (used exclusively in EuroPharma’s award-winning formulas for pain and inflammation) to Celecoxib (the generic form of Celebrex). Guess who performed better!?

EuroPharma OARSI Press Release

Leave a Reply